7k22: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 1: Line 1:


====
==Murine polyomavirus pentavalent capsomer with 8A7H5 Fab, subparticle reconstruction==
<StructureSection load='7k22' size='340' side='right'caption='[[7k22]]' scene=''>
<StructureSection load='7k22' size='340' side='right'caption='[[7k22]], [[Resolution|resolution]] 3.20&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id= OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol= FirstGlance]. <br>
<table><tr><td colspan='2'>[[7k22]] is a 15 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus_polyomavirus_1 Mus musculus polyomavirus 1] and [https://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7K22 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7K22 FirstGlance]. <br>
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=7k22 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7k22 OCA], [http://pdbe.org/7k22 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=7k22 RCSB], [http://www.ebi.ac.uk/pdbsum/7k22 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=7k22 ProSAT]</span></td></tr>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution|Resolution]] 3.2&#8491;</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7k22 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7k22 OCA], [https://pdbe.org/7k22 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7k22 RCSB], [https://www.ebi.ac.uk/pdbsum/7k22 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7k22 ProSAT]</span></td></tr>
</table>
</table>
== Function ==
[https://www.uniprot.org/uniprot/A0A247D727_POVM1 A0A247D727_POVM1] Forms an icosahedral capsid with a T=7 symmetry.[PIRNR:PIRNR003376]
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
JCPyV polyomavirus, a member of the human virome, causes Progressive Multifocal Leukoencephalopathy (PML), an oft-fatal demyelinating brain disease in individuals receiving immunomodulatory therapies. Mutations in the major viral capsid protein, VP1, are common in JCPyV from PML patients (JCPyV-PML) but whether they confer neurovirulence or escape from virus-neutralizing antibody (nAb) in vivo is unknown. A mouse polyomavirus (MuPyV) with a sequence-equivalent JCPyV-PML VP1 mutation replicated poorly in the kidney, a major reservoir for JCPyV persistence, but retained the CNS infectivity, cell tropism, and neuropathology of the parental virus. This mutation rendered MuPyV resistant to a monoclonal Ab (mAb), whose specificity overlapped the endogenous anti-VP1 response. Using cryo EM and a custom sub-particle refinement approach, we resolved an MuPyV:Fab complex map to 3.2 A resolution. The structure revealed the mechanism of mAb evasion. Our findings demonstrate convergence between nAb evasion and CNS neurovirulence in vivo by a frequent JCPyV-PML VP1 mutation.
Antibody escape by polyomavirus capsid mutation facilitates neurovirulence.,Lauver MD, Goetschius DJ, Netherby-Winslow CS, Ayers KN, Jin G, Haas DG, Frost EL, Cho SH, Bator C, Bywaters SM, Christensen ND, Hafenstein SL, Lukacher AE Elife. 2020 Sep 17;9. pii: 61056. doi: 10.7554/eLife.61056. PMID:32940605<ref>PMID:32940605</ref>
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
</div>
<div class="pdbe-citations 7k22" style="background-color:#fffaf0;"></div>
==See Also==
*[[Antibody 3D structures|Antibody 3D structures]]
*[[Virus coat proteins 3D structures|Virus coat proteins 3D structures]]
== References ==
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Large Structures]]
[[Category: Large Structures]]
[[Category: Z-disk]]
[[Category: Mus musculus polyomavirus 1]]
[[Category: Rattus norvegicus]]
[[Category: Goetschius DJ]]
[[Category: Hafenstein SL]]

Latest revision as of 16:37, 6 November 2024

Murine polyomavirus pentavalent capsomer with 8A7H5 Fab, subparticle reconstructionMurine polyomavirus pentavalent capsomer with 8A7H5 Fab, subparticle reconstruction

Structural highlights

7k22 is a 15 chain structure with sequence from Mus musculus polyomavirus 1 and Rattus norvegicus. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Method:Electron Microscopy, Resolution 3.2Å
Resources:FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT

Function

A0A247D727_POVM1 Forms an icosahedral capsid with a T=7 symmetry.[PIRNR:PIRNR003376]

Publication Abstract from PubMed

JCPyV polyomavirus, a member of the human virome, causes Progressive Multifocal Leukoencephalopathy (PML), an oft-fatal demyelinating brain disease in individuals receiving immunomodulatory therapies. Mutations in the major viral capsid protein, VP1, are common in JCPyV from PML patients (JCPyV-PML) but whether they confer neurovirulence or escape from virus-neutralizing antibody (nAb) in vivo is unknown. A mouse polyomavirus (MuPyV) with a sequence-equivalent JCPyV-PML VP1 mutation replicated poorly in the kidney, a major reservoir for JCPyV persistence, but retained the CNS infectivity, cell tropism, and neuropathology of the parental virus. This mutation rendered MuPyV resistant to a monoclonal Ab (mAb), whose specificity overlapped the endogenous anti-VP1 response. Using cryo EM and a custom sub-particle refinement approach, we resolved an MuPyV:Fab complex map to 3.2 A resolution. The structure revealed the mechanism of mAb evasion. Our findings demonstrate convergence between nAb evasion and CNS neurovirulence in vivo by a frequent JCPyV-PML VP1 mutation.

Antibody escape by polyomavirus capsid mutation facilitates neurovirulence.,Lauver MD, Goetschius DJ, Netherby-Winslow CS, Ayers KN, Jin G, Haas DG, Frost EL, Cho SH, Bator C, Bywaters SM, Christensen ND, Hafenstein SL, Lukacher AE Elife. 2020 Sep 17;9. pii: 61056. doi: 10.7554/eLife.61056. PMID:32940605[1]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

See Also

References

  1. Lauver MD, Goetschius DJ, Netherby-Winslow CS, Ayers KN, Jin G, Haas DG, Frost EL, Cho SH, Bator CM, Bywaters SM, Christensen ND, Hafenstein SL, Lukacher AE. Antibody escape by polyomavirus capsid mutation facilitates neurovirulence. Elife. 2020 Sep 17;9:e61056. PMID:32940605 doi:10.7554/eLife.61056

7k22, resolution 3.20Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA